Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Tolazamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | TP53 | P04637 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | GLA | P06280 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 0.67 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.67 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ALB | P02768 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tolazamide SCHEMBL13725632 | 1.00 | ALDH1A1 (1.00) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Tolazamide SCHEMBL28562527 | 0.98 | ALDH1A1 (0.97) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Gliclazide SCHEMBL6344915 | 0.89 | ALDH1A1 (0.88) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Tolazamide SCHEMBL27794828 | 0.88 | ALDH1A1 (0.77) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Tolazamide SCHEMBL992662 | 0.87 | ALDH1A1 (0.75) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Glypinamide SCHEMBL343885 | 0.85 | ALDH1A1 (0.74) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Tolazamide SCHEMBL2534564 | 0.84 | ALDH1A1 (0.70) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Glyclopyramide SCHEMBL49354 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Glyclopyramide SCHEMBL15669226 | 0.83 | ALDH1A1 (0.71) | ALDH1A1TP53KDM4EGLACYP3A4 | |
| Tolazamide SCHEMBL747962 | 0.80 | ALDH1A1 (0.65) | ALDH1A1TP53KDM4EGLACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 25038 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124282-A1 | DECORIN FOR ITS USE IN THE TREATMENT OF DIABETES | CENTRE EUROPEEN D'ETUDE DU DIABETE (FR) | 2026-05-07 | — | — | US | claimed |
| US-20260115210-A1 | METHOD FOR TREATING SUBJECTS SUFFERING FROM CENTRAL NERVOUS SYSTEM CONTUSIONS | REMEDY PHARMACEUTICALS, INC. (US) | 2026-04-30 | — | — | US | claimed |
| US-12611416-B2 | Methods of treating ischemic stroke at risk for cerebral or cerebellar edema | REMEDY PHARMACEUTICALS, INC. (US) | 2026-04-28 | — | — | US | claimed |
| EP-4717267-A1 | SYNERGISTIC COMBINATION FOR TREATING CANCER | FUNDACION UNIVERSITARIA SAN ANTONIO (UCAM) (ES) | 2026-04-01 | — | — | EP | claimed |
| EP-4714925-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| EP-4714928-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM WITH A HETEROCYCLIC COMPOUND COMPRISING AT LEAST ONE N-N SINGLE BOND | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| EP-4714927-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM WITH A SULFINATE AND A TERTIARY AMINE | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| EP-4714926-A1 | A REACTIVE RESIN COMPOSITION COMPRISING A PEROXIDE-FREE INITIATOR SYSTEM WITH A TERTIARY AMINE | Hilti Aktiengesellschaft (LI) | 2026-03-25 | — | — | EP | claimed |
| US-20260069550-A1 | TRANSDERMAL DELIVERY OF ANTIDIABETIC AGENTS | RITTENHOUSE CHRISTINE (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705280-A1 | DIARYL UREA-BASED COMPOUNDS AND RELATED COMPOSITIONS AND METHODS OF USE IN THE TREATMENT OF DIABETES MELLITUS AND NEURODEGENERATIVE DISEASE | Purdue Research Foundation (US) | 2026-03-11 | — | — | EP | claimed |
| US-4474752-A | DIAMINE MODIFIED POLYOXYETHYLENE-POLYOXYPROPYLENE COPOLYMER | MERCK & CO., INC. (US) | 1984-10-02 | — | — | US | claimed |
| EP-0091193-A2 | Antidiabetic compositions | PFIZER INC. (US) | 1983-10-12 | — | — | EP | claimed |
| US-4346709-A | Drug delivery devices comprising erodible polymer and erosion rate modifier | ALZA CORPORATION (US) | 1982-08-31 | — | — | US | claimed |
| US-4254109-A | INHIBIT LENS ALDOSE REDUCTASE | AYERST, MCKENNA & HARRISON INC. (CA) | 1981-03-03 | — | — | US | claimed |
| US-4254108-A | ALDOSE REDUCTASE INHIBITORS | AYERST, MCKENNA & HARRISON INC. (CA) | 1981-03-03 | — | — | US | claimed |
| EP-0007911-A4 | ZINC AND/OR CERIUM CONTAINING SULFONYLUREA HYPOGLYCEMIC AGENTS, PREPARATION AND USE THEREOF. | RESEARCH CORP (US) | 1981-02-25 | — | — | EP | claimed |
| EP-0007911-A1 | ZINC AND/OR CERIUM CONTAINING SULFONYLUREA HYPOGLYCEMIC AGENTS, PREPARATION AND USE THEREOF | Research Corporation (US) | 1980-02-06 | — | — | EP | claimed |
| WO-1979000435-A1 | ZINC AND/OR CERIUM CONTAINING SULFONYLUREA HYPOGLYCEMIC AGENTS,PREPARATION AND USE THEREOF | RESEARCH CORP (US) | 1979-07-12 | — | — | WO | claimed |
| US-4014334-A | Laminated osmotic system for dispensing beneficial agent | ALZA CORPORATION (US) | 1977-03-29 | — | — | US | claimed |
| US-4008719-A | Osmotic system having laminar arrangement for programming delivery of active agent | ALZA CORPORATION (US) | 1977-02-22 | — | — | US | claimed |